Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07038124 Ointment in Atopic Dermatitis and Plaque Psoriasis
NCT05375955Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of PF-07038124 in atopic dermatitis (AD), plaque psoriasis, sponsored by Pfizer. Started Sep 2022; status: completed.
02
Drugs
PF-07038124
03
Conditions
atopic dermatitis (AD)plaque psoriasis
Beyond the preview
Go deeper on NCT05375955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05375955.